The federal agency introduced Elsa last month, boasting about the AI tool's ability to increase efficiency at the FDA.

But three of those FDA employees told CNN that Elsa just makes up nonexistent studies, something commonly referred to in AI ...

Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is ...

FDA officials say the assistant is flawed, just as the Trump administration stresses AI adoption in healthcare.

With reports that FDA’s AI Elsa is “confidently hallucinating” studies that don’t exist, the use of AI to streamline drug review and speed up approval is not here yet.

Despite ambitions to streamline regulatory review, FDA’s Elsa platform has been prone to hallucinations, prompting internal scrutiny and questions about AI reliability and governance.

Two months after laying off 20% of its staff, Korro Bio says it has not retreated from its “3-2-1” corporate strategy as it prepares to release interim clinical data on its lead candidate KRRO-110 in ...

The mercury-based preservative thimerosal will be removed from all flu shots distributed in United States, Health and Human ...

President Donald Trump’s announcement Wednesday about his plans for artificial intelligence include a push to grow AI ...

Scammers know we're hearing plenty about immigration, tariffs, and drug trafficking. They've never been at a loss for ways to ...

California government officials are trying to find a buyer for the refinery. Giuliani said that losing the refinery would put ...

TAX TALK — Recent polling shows Michelle Wu crushing the competition in Boston’s mayoral race. Her campaign is still keeping ...